Harvard Bioscience Inc (HBIO)
3.60
+0.04
(+1.12%)
USD |
NASDAQ |
Apr 26, 16:00
3.60
0.00 (0.00%)
After-Hours: 20:00
Harvard Bioscience Cash from Financing (TTM): -12.13M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -12.13M |
September 30, 2023 | -10.75M |
June 30, 2023 | -7.621M |
March 31, 2023 | -5.824M |
December 31, 2022 | -2.837M |
September 30, 2022 | 2.487M |
June 30, 2022 | 2.597M |
March 31, 2022 | 2.983M |
December 31, 2021 | -0.252M |
September 30, 2021 | 0.511M |
June 30, 2021 | -0.929M |
March 31, 2021 | -6.037M |
December 31, 2020 | -7.967M |
September 30, 2020 | -11.75M |
June 30, 2020 | -11.46M |
March 31, 2020 | -7.691M |
December 31, 2019 | -7.624M |
September 30, 2019 | -7.549M |
June 30, 2019 | -4.189M |
March 31, 2019 | -3.195M |
December 31, 2018 | 53.05M |
September 30, 2018 | 52.97M |
June 30, 2018 | 49.54M |
March 31, 2018 | 49.72M |
December 31, 2017 | -1.792M |
Date | Value |
---|---|
September 30, 2017 | -2.563M |
June 30, 2017 | -2.863M |
March 31, 2017 | -3.41M |
December 31, 2016 | -4.868M |
September 30, 2016 | -4.819M |
June 30, 2016 | -4.206M |
March 31, 2016 | -3.098M |
December 31, 2015 | -0.54M |
September 30, 2015 | -0.478M |
June 30, 2015 | 1.297M |
March 31, 2015 | 0.529M |
December 31, 2014 | -1.234M |
September 30, 2014 | -12.61M |
June 30, 2014 | -14.73M |
March 31, 2014 | -4.465M |
December 31, 2013 | 0.068M |
September 30, 2013 | 12.02M |
June 30, 2013 | 12.03M |
March 31, 2013 | 1.772M |
December 31, 2012 | -1.063M |
September 30, 2012 | -0.426M |
June 30, 2012 | -0.367M |
March 31, 2012 | 0.527M |
December 31, 2011 | -1.141M |
September 30, 2011 | -1.167M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-12.13M
Minimum
Dec 2023
2.983M
Maximum
Mar 2022
-5.054M
Average
-6.037M
Median
Mar 2021
Cash from Financing (TTM) Benchmarks
Bruker Corp | -193.40M |
Azenta Inc | -452.51M |
Bionano Genomics Inc | 113.82M |
Akoya Biosciences Inc | 56.84M |
Singular Genomics Systems Inc | 0.696M |